NORML
JANUARY 17, 2019
A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. A similar version of this bill was passed in the House Judiciary Committee in 2018 yet was not taken up by the full chamber.
Cannabis Law Report
JUNE 2, 2021
Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Veteran suicides made up about 14% of total suicides in America in 2018, according to the U.S. None of it was initially slated to go to clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
JANUARY 22, 2020
The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important.
The Cannigma
MAY 19, 2021
While many countries around the world have legalized or decriminalized cannabis or have eased up on enforcement in recent years, in Japan in 2018 there was a sharp increase in cannabis-related arrests — and 80% of them were possession charges. of Japanese have reported consuming cannabis, as opposed to more than 40% in the US and Canada.
Project CBD
JANUARY 31, 2023
A 2018 report by the World Health Organization concluded that CBD “is generally well-tolerated with a good safety profile [and] exhibits no effects indicative of any abuse or dependence potential.” A clinical trial by ValidCare assessing CBD’s impact on human liver function has given the compound a clean bill of health.
The Cannigma
MARCH 18, 2021
Any future research or clinical trials targeting the efficacy of cannabis should clearly define these recommendations for use and prioritize the communication of such recommendations to enrolled participants,” they added.
CannaTech
SEPTEMBER 23, 2019
In the UK, cannabis-based medicinal products (CBMP) were legalized in November 2018. Last week NICE released the first draft of their evidence-based guidelines, concluding it could not recommend CBMPs for routine use because of high cost and a dearth of clinical trial evidence.
Expert insights. Personalized for you.
237 
Let's personalize your content